Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.4B
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
9.46K
-
Shares change
-
-12.4K
-
Total reported value, excl. options
-
$28K
-
Value change
-
+$18.5K
-
Number of buys
-
10
-
Number of sells
-
-1
-
Price
-
$2.96
Significant Holders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) as of Q1 2025
13 filings reported holding BLRX - BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share as of Q1 2025.
BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.46K shares
of 2.4B outstanding shares and own 0% of the company stock.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (3K shares), MORGAN STANLEY (2.24K shares), BNP PARIBAS FINANCIAL MARKETS (1.75K shares), RHUMBLINE ADVISERS (1.53K shares), JPMORGAN CHASE & CO (375 shares), Nemes Rush Group LLC (300 shares), NewEdge Advisors, LLC (107 shares), GROUP ONE TRADING LLC (79 shares), UBS Group AG (71 shares), and BANK OF AMERICA CORP /DE/ (2 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.